Krystal Biotech CEO and leadership

Mr. Krishnan brings many years of experience in the life sciences industry, having held key executive roles at several companies including, most notably, his tenure as Chief Financial Officer, Chief Operating Officer, and board member of New River Pharmaceuticals, Inc. (previously traded on NASDAQ prior to its acquisition by Shire plc in 2007). Previously, he served as a Senior Managing Director of Third Security, LLC between 2001 and 2008 and as a board member of Biotie Therapies Oyj (BTH1V:Helsinki) between 2008 and 2009. Mr. Krishnan started his career as an engineer with E.I. Dupont de Nemours in Wilmington, Delaware. He received a B.S. in Mechanical Engineering from the Indian Institute of Technology, a M.S. in Engineering from UT, Ohio, and an M.B.A. in Finance from The Wharton School at the University of Pennsylvania.

Suma Krishnan is a Chief Executive Officer at Light Matters Foundation and Founder & Chief Operating Officer at Krystal Biotech and is based in San Francisco, California. She has worked as Senior Vice President, Human Health and Therapeutic Division at INTREXON-PRECIGEN, INC. (PRECIGEN, INC.) and Sr. Vice President at New River Pharmaceuticals Inc. Suma studied at Fergusson College between 1982 and 1986 and Villanova University.

Prior to her work with CNX, Romano was the corporate controller of Rice Energy from January 2013 until the energy company was acquired by EQT in November 2017, staying on through March 2018 to assist the company the company through the transition. She also held several accounting and auditing roles at Black Box Corp. and Deloitte.

Suma Krishnan is a Chief Executive Officer at Light Matters Foundation and Founder & Chief Operating Officer at Krystal Biotech and is based in San Francisco, California. She has worked as Senior Vice President, Human Health and Therapeutic Division at INTREXON-PRECIGEN, INC. (PRECIGEN, INC.) and Sr. Vice President at New River Pharmaceuticals Inc. Suma studied at Fergusson College between 1982 and 1986 and Villanova University.

Mr. Krishnan brings many years of experience in the life sciences industry, having held key executive roles at several companies including, most notably, his tenure as Chief Financial Officer, Chief Operating Officer, and board member of New River Pharmaceuticals, Inc. (previously traded on NASDAQ prior to its acquisition by Shire plc in 2007). Previously, he served as a Senior Managing Director of Third Security, LLC between 2001 and 2008 and as a board member of Biotie Therapies Oyj (BTH1V:Helsinki) between 2008 and 2009. Mr. Krishnan started his career as an engineer with E.I. Dupont de Nemours in Wilmington, Delaware. He received a B.S. in Mechanical Engineering from the Indian Institute of Technology, a M.S. in Engineering from UT, Ohio, and an M.B.A. in Finance from The Wharton School at the University of Pennsylvania.

Suma Krishnan is a Chief Executive Officer at Light Matters Foundation and Founder & Chief Operating Officer at Krystal Biotech and is based in San Francisco, California. She has worked as Senior Vice President, Human Health and Therapeutic Division at INTREXON-PRECIGEN, INC. (PRECIGEN, INC.) and Sr. Vice President at New River Pharmaceuticals Inc. Suma studied at Fergusson College between 1982 and 1986 and Villanova University.